Related references
Note: Only part of the references are listed.Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFβ-SMMHC in acute myelogenous leukemia with inv(16)
Jan Markus et al.
CANCER RESEARCH (2007)
DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia
Shuchi Agrawal et al.
CANCER RESEARCH (2007)
Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias
CS Chim et al.
ANNALS OF HEMATOLOGY (2003)
Epigenetic targets in hematopoietic malignancies
R Claus et al.
ONCOGENE (2003)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
Epigenetic gene silencing in cancer initiation and progression
KP Nephew et al.
CANCER LETTERS (2003)
Gene silencing in phenomena related to DNA repair
T Mukai et al.
ONCOGENE (2002)
Epigenetics in cancer: implications for early detection and prevention
M Verma et al.
LANCET ONCOLOGY (2002)
Alterations of DNA methylation in hematologic malignancies
LJ Rush et al.
CANCER LETTERS (2002)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
DNA methylation changes in leukaemia
JR Melki et al.
SEMINARS IN CANCER BIOLOGY (2002)
Analysis of complex methylation data
KD Siegmund et al.
METHODS (2002)
The absence of the p15 INK4B gene alterations in adult patients with precursor B-cell acute lymphoblastic leukaemia is a favourable prognostic factor
K Hoshino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
DNA methylation profiling: A new tool for evaluating hematologic malignancies
SW French et al.
CLINICAL IMMUNOLOGY (2002)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
M Esteller et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
